Clinical Impacts

 

 

 

Prostate specific antigen

Consensus reached on prostate screening

08 August 2013

RECENT guideline statements and recommendations have led to further confusion and controversy regarding the use of Prostate Specific Antigen (PSA) testing for the early detection of prostate cancer. Despite high-level evidence for the use...

Read more

Clinical Impacts

Breast cancer

Study ties blood-pressure drugs to breast cancer

07 August 2013

WOMEN taking a common class of drugs to control high blood pressure - called calcium channel blockers or calcium antagonists - may more than double their risk for breast cancer if they continue...

Read more

Clinical Impacts

Sugar

Bowel cancer and 'sugary snacks'

19 July 2013

SNACKING on sweets and sugary treats may increase the risk of bowel cancer, a new UK study has found. The study, published in the European Journal of Cancer Prevention, is the first of...

Read more

Clinical Impacts

shutterstock 90113896

Focusing on patient engagement

27 May 2013

THE importance of effective staff engagement strategies to an organisation’s success has been known for some time. A recent investigation into the relationship between health care providers and patients at a primary care...

Read more

Clinical Impacts

shutterstock 2

Higher CPD costs for Doctors

22 April 2013

NEW Federal Government education reforms could mean higher out-of-pocket expenses for doctors continuing their medical training. From 1 July 2014, the tax deduction for work-related, self-education expenses will be capped annually at $2000 per person. Under...

Read more

Clinical Impacts

Orange XS

Soft drink links to depression

11 January 2013

A NEW study suggests that drinking more than four sweetened drinks a day, especially diet drinks, is associated with an increased risk of depression in adults. Drinking coffee was tied to a slightly...

Read more

Clinical Impacts

shutterstock 107997737

Metformin magic: new mechanism uncovered

07 January 2013

METFORMIN is an effective treatment in the reduction of overactive glucose production associated with diabetes and other disorders related to insulin resistance. It is also the most frequently prescribed drug for type 2 diabetes. Despite...

Read more

Clinical Impacts